In the AML-388 PDX model, we found a clear decrease of cells with MCL1 knockdown compared to control cells in vivo, accompanied by efficient knockdown on protein level (Fig. 2a–b), validating MCL1 as important vulnerability. Here, MCL1 is linked to acute myeloid leukemia.